News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
In the Media News & Stories
In the Media, Research
Drug bypasses suppressive immune cells to unleash immunotherapy
By recruiting the immune system to combat tumor cells, immunotherapy has improved survival rates, offering hope to millions of cancer patients. However, only about one in five people responds favorably to these treatments. With a goal of understanding and addressing immunotherapy’s limitations, researchers at Washington University School of Medicine in St. Louis have found that […]
In the Media
Some sarcoma patients improve with T cell immunotherapy
Strategy effective against some rare, aggressive sarcomas with no other treatment options A clinical trial led by researchers at Washington University School of Medicine in St. Louis has shown that a T cell immunotherapy — in which the patients’ own T cells are genetically modified to attack and kill cancer cells — is effective in […]
In the Media, Patient Resource
For Your Health – Literally Taking Steps to Boost Mental Health
In the Media, Patient Resource
For Your Health – What to Know About Young Adult Colorectal Cancer
In the Media
AI may predict spread of lung cancer to brain
Method may inform personalized cancer treatments Physicians treating patients with early-stage lung cancer face a conundrum: choosing potentially helpful yet toxic therapies such as chemotherapy, radiation or immunotherapy to knock out the cancer and lessen the risk of it spreading to the brain, or waiting to see if lung surgery alone proves sufficient. When up […]
In the Media
Medicare approves genetic test for solid tumors
Test can quickly identify treatable cancer mutations, guide precision therapy A genetic test that identifies cancer mutations in solid tumors and that was developed by researchers at Washington University School of Medicine in St. Louis has been approved for reimbursement by the Centers for Medicare & Medicaid Services (CMS). The test, known as GatewaySeq, identifies […]
In the Media, Research
Device for noninvasive brain biopsies via blood draw moves closer to market approval
A device aimed at enabling neurosurgeons and other physicians to perform noninvasive blood-based biopsies in adults with brain tumors has received Food and Drug Administration (FDA) “Breakthrough Device” designation. The device includes technology from Washington University in St. Louis and developed by Cordance Medical Inc., a medical device company in Mountain View, Calif. The designation […]
In the Media
Comprehensive Head & Neck Tumor Center established at Siteman Cancer Center
Washington University School of Medicine in St. Louis and Barnes-Jewish Hospital, a member of BJC HealthCare, have established a comprehensive Head & Neck Tumor Center, a collaborative, multispecialty practice of Washington University physicians and researchers whose mission is to provide cutting-edge care for patients with head and neck cancers as well as benign tumors and […]
In the Media, Research
Study reveals how treatment-resistant prostate cancer provides its own hormonal fuel
A new study in mice, led by researchers at Washington University School of Medicine in St. Louis, explains how prostate cancer senses a drop in testosterone levels due to common anti-hormone therapy and then begins making cholesterol — a necessary precursor to testosterone — to generate its own testosterone to fuel tumor growth. The study […]
In the Media
Siteman Cancer Center ranked No. 10 among U.S. cancer centers
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine has been named No. 10 among cancer centers nationally by U.S. News & World Report. The recognition is part of the overall ranking of Barnes-Jewish and Washington University, which are No. 11 on the news magazine’s 2022-23 “Best Hospitals” list, released today. Siteman […]